Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    MDVN

SummaryQuotesNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2013 | 10:34pm CEST

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIVATION INC
2016 Drugmaker Sanofi hungry for deals after earnings beat
2016 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
2016 PFIZER : Completes Acquisition of Medivation
2016 MEDIVATION, INC. : Termination of a Material Definitive Agreement, Completion of..
2016 PFIZER INC. (NYSE : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN) To Close ..
2016 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
2016 MEDIVATION : Highlights New Data From Differentiated Oncology Portfolio at ESMO ..
2016 PFIZER : Announces Expiration of HSR Waiting Period For Proposed Acquisition of ..
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016 PFIZER : expects to close Medivation buyout in 3Q
More news
Sector news : Bio Therapeutic Drugs
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/10 Axovant Sciences announces appointment of Dr. David Hung as CEO and expansion..
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
02/10 BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De..
02/03 Pfizer May Be Another IBM
2016 M&A Gives Signs Of Reverting To The Mean
Advertisement
Technical analysis trends MEDIVATION INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Managers
NameTitle
David T. Hung President, Chief Executive Officer & Director
Kim D. Blickenstaff Chairman
Marion McCourt Chief Operating Officer
Jennifer Jarrett Chief Financial Officer
Mohammad Hirmand Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0.00%0
AMGEN, INC.11.70%120 105
CELGENE CORPORATION7.17%96 861
GILEAD SCIENCES, INC.-4.27%89 611
REGENERON PHARMACEUTIC..5.83%41 293
VERTEX PHARMACEUTICALS..60.58%29 390
More Results